GlassScriptPhysician profile
Amy R Boyd
NPI 1558363754
$2,311.78
in general payments reported to CMS, 2019-2025
36 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $439 · 2022: $651 · 2023: $344 · 2024: $514 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $323.52 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Astellas Pharma US INC | $204.90 | 2021-2025 | Veozah |
| Novo Nordisk INC | $160.53 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $151.90 | 2021-2024 | Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $124.96 | 2021-2025 | Farxiga, Flumist Quadrivalent, Breztri |
| Abbvie INC. | $119.71 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.56 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $108.64 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $106.27 | 2021-2024 | Repatha, Otezla |
| Abbott Laboratories | $91.83 | 2021-2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $80.40 | 2021-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Pfizer INC. | $74.32 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $67.81 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.80 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.36 | 2023-2025 | Aptima, Acessa Provu System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $55.44 | 2021-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $46.58 | 2024 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $39.79 | 2021 | |
| Supernus Pharmaceuticals, INC. | $34.34 | 2021-2022 | |
| Insulet Corporation | $24.57 | 2023 | Omnipod |
| Tonix Medicines, INC. | $22.95 | 2025 | Tonmya |
| Viatris Specialty LLC | $21.95 | 2025 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $20.28 | 2025 | Rexulti |
| Medtronic, INC. | $19.10 | 2023 | Intellis Adaptivestim |
| Axonics, INC. | $18.56 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.12 | 2021 | |
| Mylan Specialty L.P. | $17.63 | 2024 | Yupelri |
| Dexcom, INC. | $16.45 | 2023 | Dexcom G6 Transmitter |
| Hikma Pharmaceuticals USA | $16.32 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.39 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.88 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $14.17 | 2024 | Xarelto |
| Eisai INC. | $13.83 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.64 | 2021 | |
| Genentech USA, INC. | $5.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.